European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Prep: Cook: Serves:

The European Union has announced the launch of the Magnetic Diagnostic Assay for Neurodegenerative Diseases (MADIA) – a project with the ultimate goal of improving diagnosis for those living with Parkinson’s and Alzheimer’s.

The project, which is in partnership with a range of international universities and institutions, will focus on the development of a novel device that will help clinicians perform a simple click and analysis to diagnose both conditions.

Dr Francisco Campos, of the Clinical Neurosciences Research Laboratory, said: “An early diagnosis is crucial to maximise the effectiveness of the treatments in order to mitigate the devastating effects of these illnesses and slow disease progression.

“MADIA is funded by the European Union’s Horizon 2020 research and innovation programme, and consists of a multitasking team with more than 50 professionals in the fields of biology, physics and engineering.”

For comprehensive information about Parkinson’s diagnosis please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

Advances

‘Project Emma’ tremor-reducing watch unveiled by Microsoft CEO

Haiyan Zhang and Emma Lawton showcase tremor-reducing device

Neurological disorders – including Parkinson’s – are leading source of disability globally

Parkinson’s is world’s fastest growing neurological disorder

VIDEO: Parkinson’s stem cell treatments explained in just 90 seconds

Watch Professor Roger Barker explain new stem cell treatments

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers in France have found that deep brain stimulation for Parkinson’s may not increase the risk of developing dementia. As part of the study – published by the American Academy of Neurology – researchers identified 175 people with Parkinson’s and an average age of 56, who had deep brain stimulation. The individuals were assessed over a period of 10 years to determine if they had developed dementia. After one year, four individuals had developed dementia. After five years, 142 people from the original group were available for testing, 12 of whom had dementia. After 10 years, 104 people were available for testing, 31 of whom had dementia. Dr Elena Moro, author of the study, said: “These results are very encouraging for people with Parkinson’s and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia.”

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

A new study reprogramming cells to replace reduced dopamine neurons in the brain could be used to reverse symptoms of Parkinson’s and other neurological conditions. As part of the study – conducted by the University of California San Diego (UCSD) – researchers found a way to convert star-shaped brain cells called astrocytes into cells producing dopamine. The team used the method to treat mouse models of Parkinson’s, administering the treatment into the areas of the brain that typically lose dopamine producing neurons. This restored reduced dopamine production to normal levels and reversed the symptoms of Parkinson’s. The researchers will continue to optimise the therapy in other mouse models of Parkinson’s before testing it on people with the condition. William Mobley, a neurosciences professor at UCSD, said: “I was stunned at what I saw. This whole new strategy for treating neurodegeneration gives hope that it may be possible to help even…

Could a magnetically powered implant treat Parkinson’s tremors?

A tiny surgical implant about the size of a grain of rice that can be implanted with minimally invasive surgery may be used to treat tremors in people with Parkinson’s. Developed by a team of researchers at Rice University, US, the implant uses a thin film of magnetoelectric material to convert acoustic waves from the brain’s magnetic field into electrical voltage. The device produces the same high-frequency signals as clinically approved implants used to treat Parkinson’s, epilepsy and other conditions – and eliminates the need for battery or wired power supply. In an initial study, the researchers showed that the implants worked in rodents. Professor Jacob Robinson, corresponding author of the study, said: “Our results suggest that using magnetoelectric materials for wireless power delivery is more than a novel idea. These materials are excellent candidates for clinical-grade, wireless bioelectronics.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

‘Project Emma’ tremor-reducing watch unveiled by Microsoft CEO

Special reports

Neurological disorders – including Parkinson’s – are leading source of disability globally

Resources & Tools

VIDEO: Parkinson’s stem cell treatments explained in just 90 seconds

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Could a magnetically powered implant treat Parkinson’s tremors?

{title}

Subscribe

European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

‘Project Emma’ tremor-reducing watch unveiled by Microsoft CEO

Special reports

Neurological disorders – including Parkinson’s – are leading source of disability globally

Resources & Tools

VIDEO: Parkinson’s stem cell treatments explained in just 90 seconds

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Could a magnetically powered implant treat Parkinson’s tremors?

{title}

Subscribe

Sign in